| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |